Parkinsons disease is a common neurological condition afflicting about 1
percent of men and women over the age of seventy. Individuals with Parkinsons
disease have tremor of the hands, rigidity, poor balance, and mild intellectual
deterioration. The tremor is most apparent at rest and is less severe with movement. In
Parkinsons disease, a small region in the brain, called the substantia nigra, begins
to deteriorate. The neurons of the substantia nigra use the brain chemical dopamine.
With the loss of dopamine, tremors begin and movement slows. Despite current drug
therapies, Parkinsons disease remains a progressive and incurable condition. Many
patients with Parkinsons disease may also suffer from age related cognitive decline
or have some of the symptoms of Alzheimers disease.
Although Parkinsons disease can
occur from viral infections or exposure to environmental toxins, such as pesticides, the
causes of the majority of cases are not well known. Scientists suspect that oxidative
damage to neurons in the substantia nigra could well be one of the major causes,
particularly due to the depletion of the antioxidant glutathione. People who sustain
substantial head injuries may face an increased risk of developing Parkinsons
disease years later. Middle-aged men and women who are overweight may be at
increased risk of developing Parkinson's disease.
The thinking and muscle problems commonly caused by Parkinson's
disease hamper driving skills in most elderly people with the progressive brain
disorder.
Treatment Strategies for Parkinsons disease
The nutritional therapy for Parkinsons disease is still an uncharted
territory. The most promising approach appears to be the use of antioxidants to slow the
oxidation and damage to the substantia nigra. Its possible that additional
nutritional approaches may be found in the future.
There are basically three types of drugs that
are commonly prescribed for patients with Parkinsons disease. First, doctors
prescribe dopamine precursors, such as L-dopa, which converts into dopamine. A second
approach is using drugs that block the breakdown of dopamine. A common medicine used for
this purpose is selegiline (also known as deprenyl). And third, drugs are provided that
influence dopamine receptors directly. The two most commonly prescribed are bromocriptine
and pergolide.
Natural supplements for
Parkinson's disease
The following antioxidants may be helpful in
addition to standard pharmaceutical therapy.
Mucuna Pruriens has been tested for Parkinson's disease
web site. You can purchase
Mucuna-Pruriens a supplement here.
Additional Nutrients to Consider
Some of the following nutrients may not be directly involved in making more
dopamine, but could well improve general cognitive abilities. Many patients who have
Parkinsons disease, especially the elderly, have age related cognitive decline.
Fish oils
at 500 to 1,000 mg a day of EPA and DHA with meals. The role of fish oils
in Parkinson’s disease is not known, but they can generally improve overall brain health.
Gingko biloba at 40 to 60 mg most days with breakfast or lunch. This herb has antioxidant
properties and helps improve memory and alertness.
Replacing hormones in patients with Parkinson’s disease may be an additional option. Whether pregnenolone, DHEA, or other hormones are helpful in Parkinsons
disease is currently not known.
Its possible that the proper use of natural supplements can reduce the necessary dose of L-dopa, selegiline, and other drugs currently used to treat Parkinsons disease, or help slow down the progression of the condition. Theres still a great deal we need to learn about the nutritional treatment of Parkinsons disease. Incorporate relaxation or stress reduction techniques into your daily life. Some forms of body work and massage are especially beneficial in Parkinson’s. The nutritional therapy for Parkinsons disease and tremor is still an uncharted territory. The most promising approach appears to be the use of antioxidants to slow the oxidation and damage to the substantia nigra. Its possible that additional nutritional approaches may be found in the future.
Food and Parkinson's disease
Large amounts of dairy products may increase in the rate of Parkinson's disease.
Intake of fruits and vegetables decreases the risk.
Prospective study of dietary pattern and risk of
Parkinson disease.
Am J Clin Nutr. 2007 Nov;86(5):1486-94. Gao X, Chen H, Fung TT,
Logroscino G, Schwarzschild MA, Hu FB, Ascherio A. Departments of Nutrition and
Epidemiology, Boston, MA.
Several studies have shown associations between Parkinson Disease risk and
individual foods and nutrients with inconsistent results. We examined
associations between dietary patterns and risk of Parkinson's disease in the
Health Professionals Follow-Up Study (1986-2002) and the Nurses' Health Study
(1984-2000). Dietary patterns with a high intake of fruit, vegetables, legumes,
whole grains, nuts, fish, and poultry and a low intake of saturated fat and a
moderate intake of alcohol may protect against Parkinson's disease.
Manganese and Parkinson's
disease
Manganese is an essential trace metal that is widely used in industry,
particularly in the manufacture of steel. Exposure to high levels of manganese
can cause toxicity to nerve cells with the development of a form of parkinsonism
known as manganism.
Blocking Dopamine Breakdown
Dopamine is broken down in the brain by an enzyme called monoamine oxidase
(MAO). When the activity of MAO is inhibited, dopamine stays around longer and this
benefits those with Parkinsons disease. Several drugs are available that block the
activity of MAO. Selegiline is the most effective and the one used most commonly. The
prescribed dosage is 5 mg a day.
No nutrients are currently known that prevent
the breakdown of dopamine. However, a study conducted on rats at the College of Humanities
and Sciences, Beijing Union University, in Beijing, China, indicates that the Chinese
herbs codonopsis and astragalus can inhibit MAO type B and increase the activity of the
antioxidant SOD. We dont have any human trials to determine whether these two herbs
would benefit patients with Parkinson’s disease. Although selegiline is a very helpful medicine, high doses
may increase the risk of heart irregularities.
Medical Treatment Strategies for Parkinsons disease
There are basically three types of drugs that
are commonly prescribed for patients with Parkinsons disease. First, doctors
prescribe dopamine precursors, such as L-dopa, which converts into dopamine. A second
approach is using drugs that block the breakdown of dopamine. A common medicine used for
this purpose is selegiline (also known as deprenyl). And third, drugs are provided that
influence dopamine receptors directly. The two most commonly prescribed are bromocriptine
and pergolide. Researchers from the
Mayo Clinic say that in some cases, patients taking pergolide (Permax) may experience
damage to heart valves.
Over the past few decades, doctors have made
important advances in the therapy of Parkinsons disease with pharmaceutical
medicines. Yet, several nutritional strategies exist which should be explored further.
Which medication to start
with?
Parkinson's disease is a degenerative brain condition in which
dopamine-producing cells in the brain gradually die off or malfunction. Dopamine
helps regulate movement, and as Parkinson's progresses, people have increasing
difficulty walking, talking and performing simple tasks. As a treatment strategy for early Parkinson's disease, both levodopa and
pramipexole appear to be similar in delaying the progression of this
neurological disease.
However, Levodopa is more likely to cause dopaminergic events, whereas
pramipexole is more likely to cause sleepiness and swelling from water
retention. Levodopa patients experience dopaminergic motor complications more
frequently than pramipexole patients. sisabling dyskinesias - involuntary muscle
movements -- were uncommon with both treatment approaches. Archives of
Neurology, March 9, 2009.
Tricyclic antidepressant nortriptyline versus SSRI
paroxetine for depression
People with Parkinson's disease who need treatment for depression seem to do
better with nortriptyline antidepressant than paroxetine, a newer medicaiton.
Dr. Matthew Menza, of the Robert Wood Johnson Medical School in Piscataway, New
Jersey, compared the older tricyclic antidepressant nortriptyline with the newer
SSRI drug paroxetine in 52 people with Parkinson's disease diagnosed with major
depression. Nortriptyline is available in generic form and under the brand name
Pamelor, and paroxetine CR is known by the brand names Paxil and Seroxat. After
8 weeks, nortriptyline was more effective than paroxetine CR. Neurology, March
10, 2009.
Parkinson drug risk
Drug therapy for
Parkinson's disease
to replace the dopamine or reduce tremors can help some patients for a while,
but symptoms eventually worsen The risk of heart valve damage with two drugs for Parkinson’s disease may be far
greater than was known. The drugs are not the main treatment for Parkinson’s,
but one is also sometimes used to treat restless legs syndrome. A study by
Italian researchers found that roughly one-fourth of Parkinson’s patients taking
pergolide or cabergoline, sold as Permax, Dostinex and other brands, had
moderate to severe heart valve problems. Another study, by German doctors, found
that users of either drug were five to seven times more likely to have leaky
heart valves than those on other types of Parkinson’s medications.
Levodopa induced dyskinesia
Levodopa induced dyskinesia is one of the most common motor complications
in advanced
Parkinson's disease. This dyskiesia involve mostly the limbs, trunk
and head, but unusual locations have been reported including respiratory
muscles, the face and the eyes.
Drug patch for Parkinson's
disease
In May of 2007, the U.S. Food and Drug Administration approved a new patch,
called Neupro, that treats Parkinson's disease symptoms. Neupro is made by
German drugs firm Schwarz Pharma. Neupro is the first transdermal patch approved
for the treatment of symptoms of Parkinson's disease. Neupro patch delivers a
drug called rotigotine. Rotigotine is similar to other drugs used to treat
Parkinson's -- it is a so-called dopamine agonist, which provides more dopamine.
The Neupro patch is replaced every 24 hours and provides a continuous dose of
the drug. The most common side effects for Neupro included skin reactions at the
patch site, dizziness, nausea, vomiting, drowsiness and insomnia, most of which
are typical of this class of drugs.
Family history and
Parkinson's disease
Immediate relatives (brother, sister, mother, father, son or daughter) of
patients with Parkinson's disease are at increased risk for developing
depression and anxiety disorders which suggests a genetic relationship. Archives
of General Psychiatry, December 2007.
Ovary removal may increase
risk of Parkinson's disease
Women who have had removal of one or both ovaries prior to menopause are
at increased risk of developing Parkinson's disease or similar conditions.
Estrogen protects the brain's neurons and thereby may decrease the risk of
Parkinson's disease.
Pesticides and insecticides
as a cause
On-the-job pesticide exposure increases the risk for Parkinson's disease. French
researchers found that among nearly 800 adults with and without Parkinson's,
agricultural workers exposed to pesticides -- including insecticides, weed
killers and fungicides -- were at greater risk of the disease. The risk climbed
in tandem with the amount of time a worker was exposed, strengthening the case
for a cause-effect relationship, according to the researchers, led by Dr. Alexis
Elbaz of INSERM, the national French institute for health research in Paris. In
men, among the main groups of pesticides -- fungicides, herbicides, insecticides
-- the association was the strongest for insecticides, and among insecticides,
with organochlorine insecticides, which have been frequently used in France in
the past. Annals of Neurology, June 4, 2009.
Dr. Jason R. Richardson of the Robert Wood Johnson Medical School in Piscataway, New Jersey, reports that Parkinson's disease patients are more likely to have detectable levels of beta-hexachlorocyclohexane (beta-HCH) in their blood, and also had higher average levels, than healthy individuals or Alzheimer's disease patients. Beta-HCH belongs to a class of pesticides known as organochlorines, which were banned in the US in the 1970s. But these pesticides can persist in the environment -- and in people's bodies -- for decades. Archives of Neurology, July 2009.
Do NSAIDs protect against
Parkinson's disease?
Some studies find that NDAIDs protect agains Parkinson's disease while
others have not found such a relationship.
Nonsteroidal anti-inflammatory drugs may protect against Parkinson
disease.
Neurology. 2007 Nov 6;69(19):1836-42. Wahner AD, Bronstein JM,
Bordelon YM, Ritz B. Department of Epidemiology, UCLA School of Public
Health, Box 951772, 650 Charles E. Young Drive, Los Angeles, CA
90095-1772, USA.
Markers of neuroinflammation, including activated microglia and increased
levels of circulating proinflammatory cytokines, have been observed in the
brains and CSF of patients with Parkinson disease. Our study contributes
to the growing body of literature suggesting a protective role for
nonsteroidal anti-inflammatory drugs (NSAIDs) in Parkinson disease. Given
our results and the biologic plausibility of a neuroprotective function
for NSAIDs there is a pressing need for further studies elucidating the
protective role such drugs may play in Parkinson's disease.
Nonsteroidal anti-inflammatory drugs and the risk of
Parkinson disease.
Neuroepidemiology. 2007;28(4):193-6. Department of Epidemiology and
Biostatistics, Erasmus Medical Center, Rotterdam, The Netherlands.
Several lines of evidence suggest a role of inflammatory processes in
Parkinson disease, although it is still unclear whether inflammation is a
cause or rather a consequence of neurodegeneration. In a prospective
population-based cohort study among 6,512 participants aged >or=55 years,
with repeated in-person examination, we evaluated the association between
cumulative use of nonsteroidal anti-inflammatory drugs (NSAIDs) and the
risk of Parkinson disease. Complete information on filled prescriptions
was available from automated pharmacy records. Data were analyzed by means
of Cox proportional hazards regression analysis, adjusted for age, sex,
smoking habits and coffee consumption. After an average 9 years of
follow-up, 88 new cases of Parkinson disease were detected. No association
was found between use of NSAIDs and the risk of Parkinson disease
(adjusted hazard ratio for any NSAID use. Our findings do not support the
hypothesis that NSAIDs might decrease the risk of Parkinson disease.
Parkinson's disease emails
Q. I've been trying to keep you aware of my condition; The Parkinsons disease I
have. the mucuna pruriens has helped greatly, I've improved even more. The
shaking is very much better and the memory is getting better. My DR. is
surprised I showed him the product and he is considering having a mucuna bottle
in his office to reccomend to patients.
Q. I have Parkinson disease and I beg you to
answer to me if Mind Power Rx is right supplement for me.
A. We cannot predict any person's response to a particular
supplement, it is impossible for us to say whether a product such as Mind Power
Rx will help or not, all we can do is give general research on the topic of
Parkinson's Disease.
Q. I have Parkinson disease taking mucuna at present would
your other supp. mind power rx be better on ltd income due to illness any info
appreciated thank you.
A. It is impossible to predict whether Mind Power would help or not
help. If you do choose to use Mind Power Rx, we would suggest reducing the dose
of mucuna to avoid overstimulation and have your doctor supervise you.
Q. Sir, will Mind Power Rx formula aid a person
with Parkinson's disease ? Is there a special formula that may help control the
symptoms of Parkinson disease ?
A. There have not been any studies with Mind Power Rx in regards to
Parkinson's disease. You may ask your doctor to read the research on this page
in regards to Parkinson's disease option with natural supplements.
Q. I have severe Parkinson's disease with motor
fluctuations and am on Sinemet etc. Can I use choline supplement? What should I
watch for? Which preparation is the best for me to use?
A. It is difficult to predict for each person how a supplement will
interact with their medical condition or medication. We have not seen much
research with Parkinson's disease and choline supplements.
Q. I am considering using natural products to
supplement or replace my existing regimen of Sinemet LDOPA, Mirapex, Comtan and
Selegiline. What of your products would you recommend and why. Also a byproduct
of taking these meds is erectile dysfunction. I understand these natural
products my help me there as well.
A. We suggest your doctor reads this page on Parkinson's disease.
We cannot make individual suggestions. If natural supplements such as mucuna
pruriens are started, the dosage of the other drugs may need to be reduced since
overstimulation can occur.
Q. I recently discovered mucuna pruriens product
and I have been taking 3 pills daily or about a month as a secondary dopamine
support to my daily prescription of Carbodopa / Levodopa. I had a stem cell
treatment for
Parkinson's almost a year ago and the thought is that the stem cells will
develop into dopamine producing cells as needed. My hope is to wean off of the
prescription drugs and use the mucuna pruriens product to help keep my
dopamine levels more stable while this regeneration takes place. What do you
consider to be the maximum mucuna dosage a person could take without risk of
serious side effects or other complications? I'd like to see if I could just use
the natural dopamine and get off the prescription drugs all together.
A. Each person is different in the mucuna pruriens dosage that
works for them. One dosage may work well for one person but have side effects
for another. We cannot give a specific answer since each person would need to
find out for themselves in consultation with their doctor. Plus, each person may
have a different dosage of the other medicines they are taking for Parkinson's
disease and interactions are not easy to predict.
Q. Have read your literature regarding L-tyrosine
and its possible uses as a supplement. Since it is a precursor of dopa, is there
any literature related to using L-tyrosine as an effective supplement during
early Parkinsons in replacing dopa in the brain?
A. Tyrosine is not an effective treatment for Parkinson's disease.
Q. I am 80 years old. I got Parkinson's disease about 3 years ago. Two Years ago I went to the Mayo Clinic in Rochester. I was diagnosed, by the doctor/s there, with Parkinson's disease. My main problems are writing very small and walking (I no longer have the coordination to play tennis, skip rope and swim) but I have no tremors. My Doctor here in Toronto recommended I take Levo Dopa (8 pills/day) which I have been taking for 2 years now. About 1 to 1- 1/2 years ago I lost quite bit of my balance and began to use a cane and at times a walker. I have fallen down quite a few times. Fortunately I am in good shape and have not broken any bones. About 6 months ago I hired a personal trainer and found him to be very capable. His training technique includes discouraging me from walking with a cane and walker. This past March 2008 I went on cruise and began taking Mucana Pruriens and slowly I stopped taking the Levo Dopa prescribed. Now I am taking 2-3 Mucana pills per day + 1-2 Curcumin Tumeric pills per day. I must tell you that since I have been taking the Curcumin Tumeric pills my skin texture has improved and my friends tell me my overall appearance has improved. In addition my eyes look better (no redness) plus my eyesight has improved. I saw a new top doctor recently by the name of Tony Lange who's specialty is movement (it took me 2 years to get this appointment). He gave me an extremely thorough examination this past June. He diagnosed me with Parkinson's disease as well and he ordered an MRI for my brain.
I just thought I would put out my thoughts on Glutathione. My husband was diagnosed with stage 4 Parkinson’s in May ’06 at age 47. We researched the current drugs available, talked to PD patients throughout the world, talked to researches that would come out with “new” PD drugs and decided to stay away from the PD medical drugs. We ended up going completely holistic and stumbled upon Glutathione. At a time when my husband could barely walk out the front door to the mailbox and back, I chose to fly him out of town to Idaho Falls, ID to a natural healer who had someone from Hawaii dispensing Glutathione in IV format. For one week my husband received 4000mgs. everyday for 6 days and then flew home. I was amazed at the results. We were able to walk for 3 miles with no problems. I then flew him back out for another 2 weeks of treatment. One day they even gave him 50,000mgs of Glutathione. (My thoughts are the body takes what it needs and dispenses the rest) They also included a small amount of magnesium. He was symptom free for 4 months. Unfortunately, this process cost us several thousand dollars. I’m not complaining because it was clear to me that GSH (Glutathione) was a powerful answer for us....no side effects & very healthy. We then spent a huge amount of time trying to find a local doctor to continue treatment at home. We couldn’t find one doctor (we’re in Cincinnati) or even a neurologist who would look at giving my husband 4000mgs a week. We finally found out about Dr. David Perlmutter in Naples, FL (he’s a neurologist) who pioneered a study on Glutathione for Parkinson’s patients. I flew my husband out to see him & I was taught how to give IV’s to my husband. We now have it shipped to our home in batches of 10 treatments @ 4000 mgs & I give him his IV’s myself. We see a local neurologist who has told us that he really doesn’t need to go on the PD drugs because whatever we’re doing it’s working. We still get our GSH through Dr. David Perlmutter and sent to us from Wellness Pharmacy, a compounding pharmacy. It works and it keeps the major debilitating symptoms at bay. He is not cured but he is an anomaly for a typical Parkinson’s patient. He was really bad in 2006 and yet he continues to improve. He has never been as bad as he was in the beginning but he is still not 100% better. He hates getting an IV and I hate giving it to him but we both know it’s necessary to keep him as healthy as we can.
My dad has been diagnosed with Parkinson's in the
last few years. He is 76 and has a shake in his hand, it has also progressed to
what he calls a rattle in his teeth so sometimes he has a tremor in his face. He
was on cholesterol lowering tablets but he has managed to get his cholesterol
down so is no longer on meds for cholesterol. He is also on Regurin trospium and
Avodart meds and takes one aspirin a day. He was in a serious accident in 2007
where he suffered a hematoma and fractures to the skull so I am not sure if this
caused the Parkinsons to progress further. He was on meds for this neurological
condition (half Inderal) for essential tremor and another tablet think it had
ledovopa in it but he had adverse reaction to these meds. Can my father take
Co-Enzyme Q10? I have heard that this can delay parkinson's in some patients. Is
there anything he can take that might help the shake in his hand?
Thus far most studies have not shown that coenzyme Q10 has a
major influence on this neurological condition.
Following my diagnosis of Parkinsons, I revisited
my daugter's focusing issues identified at age 5 -- termed ADD. Looking over
your site most issues adress ADHD and she has no hyperactivity or bvior problems
whatsoever. We tried the Ritalin drugs - very distressing. Would Mucuna Puriens,
Tyrosine or Phenylanaline have a positive impact - if so which ones to take or
combine or should I go in another direction?
It's not easy to predict which supplement and at what dosage
or combination would be helpful without trying them.
Home -
tongkat ali home